← Back to Research Radar
Academic Publication Academic Publication

Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales

31
Citations
November 1, 2024
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
recent developments topoisomerase inhibitors clinical trials
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
42%
🔥

Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales

No description provided.
crossref.org › academic paper
0%

Imetelstat, a novel, first‐in‐class telomerase inhibitor: Mechanism of action, clinical, and translational science

AbstractMost cancers and neoplastic progenitor cells have elevated telomerase activity and preservation of telomeres that promote cellular immortality, making telomerase a rational target for the t...
crossref.org › academic paper
0%

Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies

AbstractAlzheimer’s disease (AD) stands as the predominant form of dementia, presenting significant and escalating global challenges. Its etiology is intricate and diverse, stemming from a combinat...
roipad.com › trend story
0%

Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases

Collaboration combines Evogene's AI-driven computational chemistry platform with ELEO's proprietary biological capabilities to accelerate the discovery of novel oral therapies targeting a multi-bil...
crossref.org › academic paper
0%

Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines

Abstract The ability of small nucleic acids to modulate gene expression via a range of processes has been widely explored. Compared with conventional treatments, small nucleic aci...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales'?

This literature focuses on:

Are there open-source GitHub repositories related to Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales?

Yes, open-source projects like Kappaemme-git/codex-first-customer-finder-skill (A Codex skill that finds evidence-backed potential first customers from recent public signals.) are actively building upon these concepts.

Which startups are commercializing the technology behind Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales?

Products like Chronicle are bringing this to market. Their focus is: Build Codex memories from recent screen context..

What other academic literature is closely related to 'Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales'?

Yes, highly correlated activity was mapped. An entry titled 'Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales' discusses this: No description provided.

Are there commercial applications of 'Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales' in market news publications?

Yes, highly correlated activity was mapped. An entry titled 'Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases' discusses this: Collaboration combines Evogene's AI-driven computational chemistry platform with ELEO's proprietary biological capabilities to accelerate the disco...

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Enterprise Ecosystem Mentions

Associated Media Narrative